Last reviewed · How we verify
NCT04906551: EMBeD
Measuring Endometrial Blood Flow Using Laser Doppler: Acceptability & Reproducibility
trial testing laser Doppler in Endometrium in 35 participants. Status unknown.
6 June 2022
Quick facts
| Lead sponsor | Birmingham Women's and Children's NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 35 |
| Start date | 7 June 2021 |
| Primary completion | 6 June 2022 |
| Estimated completion | 6 June 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- laser Doppler
Conditions studied
- Endometrium — all drugs for Endometrium →
- Vascularization — all drugs for Vascularization →
Sponsor
Birmingham Women's and Children's NHS Foundation Trust
Who can join
Adults 18 to 40, female only, with Endometrium or Vascularization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
35 participants will be recruited from a list of patients who are scheduled, as part of their routine NHS care, to have a clinically-indicated outpatient hysteroscopy for assessment of their uterine cavity. The participants will be women from the age of 18 up to the age of 40 who are undergoing hysteroscopy investigation. All participants included in the study require at least one ultrasound scan, within the preceding 5 years, demonstrating the presence of a normal uterine cavity devoid of uterine anomalies such as a septate uterus or intrauterine fibroids (which may affect endometrial blood flow measurements). It is usual for a patients to have an ultrasound assessment prior to hysteroscopy therefore we do not anticipate this requirement limiting the number of eligible participants available.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04906551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of laser Doppler
Trials testing the same drug.
- NCT04321434 — Hyperoxia and Microvascular Dysfunction · NA · terminated
Other recruiting trials for Endometrium
Currently open trials in the same condition.
- NCT00587886 — Estrogen, Diet, Genetics and Endometrial Cancer · active not recruiting
Other Birmingham Women's and Children's NHS Foundation Trust trials
Trials by the same sponsor.
- NCT05735977 — Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared · NA · completed
- NCT05971563 — Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers · NA · completed
- NCT05702294 — Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries . · NA · completed
- NCT04854018 — Indo-cyanine Green (ICG) in Paediatric Oncology MIS · Phase 4 · completed
- NCT04751500 — The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04906551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Birmingham Women's and Children's NHS Foundation Trust
- Last refreshed: 23 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04906551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing